Clinical evaluation shows the EXENT System's diagnostic sensitivity for monoclonal gammopathy and potential for broader use, emphasizing isotype recognition.
Key Points
Diagnostic sensitivity for monoclonal gammopathies was 92.6%, indicating strong performance by the EXENT System in detecting these conditions.
Diagnostic sensitivity for specific conditions ranged from 83.6% for AL amyloidosis to 100% for smoldering multiple myeloma, showcasing excellent test reliability.
The EXENT System outperformed serum protein electrophoresis in identifying M-proteins, suggesting an improvement in diagnostic capabilities for monoclonal gammopathy.
While not first-line, the assay's strong diagnostic performance may integrate into diagnostic algorithms for monoclonal gammopathies.